Statistical methods for assessing drug interactions using observational data

References

• M. Ataei, F.M. Shirazi, R.J. Lamarine, S. Nakhaee, and O. Mehrpour, A double-edged sword of using opioids and COVID-19: A toxicological view, Subst. Abuse. Treat. Prev. Policy. 15 (2020), pp. 1–4.
   PubMed Web of Science ®Google Scholar
• P.C. Austin and E.A. Stuart, Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies, Stat. Med. 34 (2015), pp. 3661–3679.
   PubMed Web of Science ®Google Scholar
• K. Baxter, Stockley's Drug Interactions, Pharmaceutical Press, London, 2008.
   Google Scholar
• M.A. Brookhart, S. Schneeweiss, K.J. Rothman, R.J. Glynn, J. Avorn, and T. Sturmer, Variable selection for propensity score models, Am. J. Epidemiol. 163 (2006), pp. 1149–1156.
   PubMed Web of Science ®Google Scholar
• S.R. Cole and M.A. Hernan, Constructing inverse probability weights for marginal structural models, Am. J. Epidemiol. 168 (2008), pp. 656–664.
   PubMed Web of Science ®Google Scholar
• J.A. Craycroft, J. Huang, and M. Kong, Propensity score specification for optimal estimation of ATE with binary response, Stat. Methods. Med. Res. 29 (2020), pp. 3623–3640.
   PubMed Web of Science ®Google Scholar
• L.B. Daniels, J. Ren, K. Kumar, Q.M. Bui, J. Zhang, X. Zhang, M.A. Sawan, H. Eisen, C.A. Longhurst, and K. Messer, Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: findings from the American heart association's COVID-19 cardiovascular disease registry, PLoS. ONE. 16 (2021), pp. e0254635.
   PubMed Web of Science ®Google Scholar
• T.M.C. de Lucena, A.F. da Silva Santos, B.R. de Lima, M.E. de Albuquerque Borborema, and J. de Azevedo Silva, Mechanism of inflammatory response in associated comorbidities in COVID-19, Diabetes Metab Syndr 14 (2020), pp. 597–600.
   PubMed Web of Science ®Google Scholar
• A. De Spiegeleer, A. Bronselaer, J.T. Teo, G. Byttebier, G. De Tre, L. Belmans, and R. Dobson et al, The effects of ARBs, ACEis, and statins on clinical outcomes of COVID-19 infection among nursing home residents, J. Am. Med. Dir. Assoc. 21 (2020), pp. 909–914.
   PubMed Web of Science ®Google Scholar
• H.B. Fang, G.L. Tian, and M. Tan, Hierarchical models for tumor xenograft experiments in drug development, J. Biopharm. Stat. 14 (2004), pp. 931–945.
   PubMedGoogle Scholar
• A.J. Garber, D.S. Donovan Jr, P. Dandona, S. Bruce, and J.S. Park, Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetes, The Journal of Clinical Endocrinology $\mathrm{\&}$ Metabolism 88 (2003), pp. 3598–3604.
   PubMed Web of Science ®Google Scholar
• A. Gelman and J. Hill, Data Analysis Using Regression and Multilevel/Hierarchical Models, Cambridge University Press, 2006.
   Google Scholar
• S. Greenland and M.A. Mansournia, Limitations of individual causal models, causal graphs, and ignorability assumptions, as illustrated by random confounding and design unfaithfulness, Eur. J. Epidemiol. 30 (2015), pp. 1101–1110.
   PubMed Web of Science ®Google Scholar
• M.A. Hernan and J.M. Robins, Causal Inference: What If, Chapman & Hill/CRC, Boca Raton, FL, 2020.
   Google Scholar
• K. Hirano and G.W. Imbens, The propensity score with continuous treatments, in Applied Bayesian Modeling and Causal Inference from Incomplete-data Perspectives, A. Gelman and X. Meng, eds., Wiley, New York, 2004, pp. 73–84
   Google Scholar
• D.G. Horvitz and D.J. Thompson, A generalization of sampling without replacement from a finite universe, J. Am. Stat. Assoc. 47 (1952), pp. 663–685.
   Web of Science ®Google Scholar
• G.W. Imbens, The role of the propensity score in estimating dose-response functions, Biometrika 87 (2000), pp. 706–710.
   Web of Science ®Google Scholar
• K. Imai and M. Ratkovic, Covariate balancing propensity score, J. R. Stat. Soc.: Series B (Statistical Methodology) 76 (2014), pp. 243–263.
   Web of Science ®Google Scholar
• J.D. Kang and J.L. Schafer, Demystifying double robustness: A comparison of alternative strategies for estimating a population mean from incomplete data, Stat. Sci. 22 (2007), pp. 523–539.
   Web of Science ®Google Scholar
• M. Kong and J.J. Lee, A generalized response surface model with varying relative potency for assessing drug interaction, Biometrics 62 (2006), pp. 986–995.
   PubMed Web of Science ®Google Scholar
• J.J. Lee, M. Kong, G.D. Ayers, and R. Lotan, Interaction index and different methods for determining drug interaction in combination therapy, J. Biopharm. Stat. 17 (2007), pp. 461–480.
   PubMed Web of Science ®Google Scholar
• B.K. Lee, J. Lessler, and E.A. Stuart, Weight trimming and propensity score weighting, PLoS. ONE. 6 (2011), pp. e18174.
   PubMed Web of Science ®Google Scholar
• T. Lumley, Analysis of complex survey samples, J. Stat. Softw. 9 (2004), pp. 1–19.
   Google Scholar
• F. Li and F. Li, Propensity score weighting for causal inference with multiple treatments, Ann. Appl. Stat. 13 (2019), pp. 2389–2415.
   Web of Science ®Google Scholar
• D.C. Malone, E.P. Armstrong, J. Abarca, A.J. Grizzle, P.D. Hansten, R.C. Van Bergen, B.S. Duncan-Edgar, S.L Solomon, and R.B. Lipton, Identification of serious drug-drug interactions: Results of the partnership to prevent drug-drug interactions, J. Am. Pharm. Assoc. (2003) 44 (2004), pp. 142–151.
   PubMedGoogle Scholar
• D.F. McCaffrey, B.A. Griffin, D. Almirall, M.E. Slaughter, R. Ramchand, and L.F. Burgette, A tutorial on propensity score estimation for multiple treatments using generalized boosted models, Stat. Med. 32 (2013), pp. 3388–3414.
   PubMed Web of Science ®Google Scholar
• R. Mokhtari, T.S. Homayouni, N. Baluch, E. Morgatskaya, S. Kumar, B. Das, and H. Yeger, Combination therapy in combating cancer, Oncotarget 8 (2017), pp. 38022–38043.
   PubMedGoogle Scholar
• C.Z. Mooney and R.D. Duval, Bootstrapping: A Nonparametric Approach to Statistical Inference, SAGE Publications Inc., Thousand Oaks, CA, 1993.
   Google Scholar
• J.C. Naveiro-Rilo, D. Diez-Juarez, M.L. Flores-Zurutuza, P. Javierre Perez, C. Alberte Perez, and R. Molina Mazo, Quality of life in the elderly on polymedication and with multiple morbidities, Rev. Esp Geriatr Gerontol 49 (2014), pp. 158–164.
   PubMedGoogle Scholar
• Y. Noguchi, T. Tachi, and H. Teramachi, Review of statistical methodologies for detecting drug-drug interactions using spontaneous reporting systems, Front. Pharmacol. 10 (2019), pp. 1319.
   PubMed Web of Science ®Google Scholar
• A. Oesterle, U. Laufs, and J.K. Liao, CPleiotropic effects of statins on the cardiovascular system, Circ. Res. 120 (2017), pp. 229–243.
   PubMed Web of Science ®Google Scholar
• J.M. Robins, M.A. Hernan, and B. Brumback, Marginal structural models and causal inference in epidemiology, Epidemiology 11 (2000), pp. 550–560.
   PubMed Web of Science ®Google Scholar
• P.R. Rosenbaum and D.B. Rubin, The central role of the propensity score in observational studies for causal effects, Biometrika 70 (1983), pp. 41–55.
   Web of Science ®Google Scholar
• D.B. Rubin, Causal inference using potential outcomes: Design, modeling, decisions, Journal of the American Statistical Association 100 (2005), pp. 322–331.
   Web of Science ®Google Scholar
• B. Strack, J.P. DeShazo, C. Gennings, J.L. Olmo, S. Ventura, K.J. Cios, and J.N. Clore, Impact of HbA1c measurement on hospital readmission rates: Analysis of 70, 000 clinical database patient records, Biomed. Res. Int. (2014), doi: 10.1155/2014/781670.
   PubMed Web of Science ®Google Scholar
• N.P. Tatonetti, P.P. Ye, R. Daneshjou, and R.B. Altman, Data-driven prediction of drug effects and interactions, Sci. Transl. Med. 4 (2012), pp. 125ra31–125ra31.
   PubMed Web of Science ®Google Scholar
• K. Tikoo, G. Patel, S. Kumar, P.A. Karpe, M. Sanghavi, V. Malek, and K. Srinivasan, Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: Role of epigenetic histone modifications, Biochem. Pharmacol. 93 (2015), pp. 343–351.
   PubMed Web of Science ®Google Scholar
• M.Y. Tramontina, M.B. Ferreira, M.S. Castro, and I. Heineck, Comorbidities, potentially dangerous and low therapeutic index medications: Factors linked to emergency visits, Ciencia $\mathrm{\&}$ Saude Coletiva 23 (2018), pp. 1471–1482.
   PubMed Web of Science ®Google Scholar
• T. VanderWeele, Explanation in Causal Inference: Methods for Mediation and Interaction, Oxford University Press, New York, NY, 2015.
   Google Scholar
• T.J. VanderWeele and M.J. Knol, A tutorial on interaction, Epidemiol. Method. 3 (2014), pp. 33–72.
   Google Scholar
• N. Vogt-Ferrier, Older patients, multiple comorbidities, polymedication ···  should we treat everything?, Eur. Geriatr. Med. 2 (2011), pp. 48–51.
   Web of Science ®Google Scholar
• X. Yan, Y. Abdia, S. Datta, K.B. Kulasekera, B. Ugiliweneza, M. Boakye, and M. Kong, Estimation of average treatment effects among multiple treatment groups by using an ensemble approach, Stat. Med. 38 (2019), pp. 2828–2846.
   PubMed Web of Science ®Google Scholar
• Z. Zhang, H.J. Kim, G. Lonjon, and Y. Zhu, Balance diagnostics after propensity score matching, Ann. Transl. Med. 7 (2019), pp. 16.
   PubMed Web of Science ®Google Scholar
• W. Zhao and H. Yang, Statistical Methods in Drug Combination Studies, Vol. 69, CRC Press, 2014.
   Google Scholar
• H Zou and T. Hastie, Regularization and variable selection via the elastic net, J. R. Stat. Soc.: Series B (Stat. Methodol.) 67 (2005), pp. 301–320.
   Google Scholar